Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space

被引:44
作者
Ermondi, Giuseppe [1 ]
Vallaro, Maura [1 ]
Goetz, Gilles [2 ]
Shalaeva, Marina
Caron, Giulia [1 ]
机构
[1] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Quarello 15, I-10135 Turin, Italy
[2] Pfizer Inc, Discovery Sci, Hit Discovery & Optimizat, WWRD, Eastern Point Rd, Groton, CT 06340 USA
关键词
Beyond rule of 5; Chameleonicity; Ionization; Lipophilicity; Permeability; Polarity; Property-based drug design; DRUG DISCOVERY; LIPOPHILICITY DETERMINATION; ORAL BIOAVAILABILITY; MOLECULAR-PROPERTIES; IAM CHROMATOGRAPHY; HPLC; PREDICTION; DESIGN; INDEX; TOOL;
D O I
10.1016/j.ejps.2020.105274
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Beyond rule of 5 (bRo5) molecules are attracting significant interest in modern drug discovery mostly because many novel targets require large and more flexible structures. The main aim of this paper is the identification of ad hoc bRo5 physicochemical descriptors of ionization, lipophilicity, polarity and chameleonicity and their measurement. We used different methods to collect ionization (pK(a) measures and log k'80 PLRP-S trends), lipophilicity (in octanol/water, in apolar systems and in biomimetic environments), polarity (Delta log P-oct (- to1), EPSA and Delta log K-w(IAM)) and chameleonicity (ChameLogD) descriptors for 26 bRo5 drugs. A second aim was to check the relationship between physicochemical descriptors and permeability for a subset of compounds for which solid permeability values are reported in the literature. Results showed that the physicochemical profile in the bRo5 chemical space is often experimentally accessible, albeit more tools are required to overcome limitations of individual methods. For the investigated compounds, permeability is governed by Delta log P(oct-)(to1)( )and preliminary data support that chameleonicity could also have an impact.
引用
收藏
页数:9
相关论文
共 49 条
[1]   Application of hydrogen bonding calculations in property based drug design [J].
Abraham, MH ;
Ibrahim, A ;
Zissimos, AM ;
Zhao, YH ;
Comer, J ;
Reynolds, DP .
DRUG DISCOVERY TODAY, 2002, 7 (20) :1056-1063
[2]   Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space [J].
Alex, Alexander ;
Millan, David S. ;
Perez, Manuel ;
Wakenhut, Florian ;
Whitlock, Gavin A. .
MEDCHEMCOMM, 2011, 2 (07) :669-674
[3]  
[Anonymous], EXPERT OPIN DRUG DIS
[4]  
[Anonymous], [No title captured]
[5]  
[Anonymous], 2019, FUTUR DRUG DISCOV
[6]  
Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100
[7]   Comparative evaluation of pKa prediction tools on a drug discovery dataset [J].
Balogh, Gyoergy T. ;
Tarcsay, Akos ;
Keseru, Gyoergy M. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 67-68 :63-70
[8]   Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space [J].
Caron, Giulia ;
Digiesi, Vito ;
Solaro, Sara ;
Ermondi, Giuseppe .
DRUG DISCOVERY TODAY, 2020, 25 (04) :621-627
[9]   Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry [J].
Caron, Giulia ;
Kihlberg, Jan ;
Ermondi, Giuseppe .
MEDICINAL RESEARCH REVIEWS, 2019, 39 (05) :1707-1729
[10]   Updating molecular properties during early drug discovery [J].
Caron, Giulia ;
Ermondi, Giuseppe .
DRUG DISCOVERY TODAY, 2017, 22 (06) :835-840